Artwork

Content provided by Plenary Session. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Plenary Session or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

2.13 BONUS! RCTs Supporting Approvals of Cancer Drugs by EMA with Dr. Huseyin Naci

39:32
 
Share
 

Manage episode 242581522 series 2421870
Content provided by Plenary Session. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Plenary Session or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
On this week's BONUS episode, we sit down with Dr. Huseyin Naci, Assistant Professor of Health Policy at the London School of Economics, to discuss his new paper that came out Wednesday (producer's edit: not "yesterday" as said in the podcast - apologies for the delay!) in the British Medical Journal. The paper's titled "Design characteristics, risk of bias, and reporting of randomised controlled trials supporting approvals of cancer drugs by European Medicines Agency, 2014-16: cross sectional analysis." RCTS Supporting Approvals: doi.org/10.1136/bmj.l5221 Back us on Patreon! patreon.com/plenarysession
  continue reading

375 episodes

Artwork
iconShare
 
Manage episode 242581522 series 2421870
Content provided by Plenary Session. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Plenary Session or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
On this week's BONUS episode, we sit down with Dr. Huseyin Naci, Assistant Professor of Health Policy at the London School of Economics, to discuss his new paper that came out Wednesday (producer's edit: not "yesterday" as said in the podcast - apologies for the delay!) in the British Medical Journal. The paper's titled "Design characteristics, risk of bias, and reporting of randomised controlled trials supporting approvals of cancer drugs by European Medicines Agency, 2014-16: cross sectional analysis." RCTS Supporting Approvals: doi.org/10.1136/bmj.l5221 Back us on Patreon! patreon.com/plenarysession
  continue reading

375 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide